ALK and T-cell non-Hodgkin lymphoma: Marzec et al. first reported that in NPM-ALK-rearranged T-cell lymphoma cell models, NPM-ALK fusion could induce PD-L1 expression via direct transcriptional activation by STAT3 at the PD-L1 promoter [45].